Skip to main content
Stephen Hunger, MD, Pediatric Hematology & Oncology, Philadelphia, PA, Children's Hospital of Philadelphia

StephenPHungerMD

Pediatric Hematology & Oncology Philadelphia, PA

Chief, Division of Oncology- Children's Hospital of Philadelphia (CHOP)

Dr. Hunger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hunger's full profile

Already have an account?

  • Office

    3401 Civic Center Blvd
    Childrens Hospital Of Philadelphia
    Philadelphia, PA 19104
    Phone+1 215-590-3535
    Fax+1 215-590-3992
  • Is this information wrong?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1988 - 1991
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1985 - 1988
  • Uconn School Of Medicine
    Uconn School Of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - Present
  • FL State Medical License
    FL State Medical License 2001 - Present
  • PA State Medical License
    PA State Medical License 2015 - 2024
  • NY State Medical License
    NY State Medical License 2015 - 2023
  • CO State Medical License
    CO State Medical License 1994 - 2015
  • MD State Medical License
    MD State Medical License 1987 - 1988
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic Leukemia  
    Nyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature
  • Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group  
    Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
  • Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
    Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

  • Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy
    Stephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...
    Stephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in Children
    Stephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Children's Hospital of Philadelphia Names Chief of Hematologic Malignancies
    Children's Hospital of Philadelphia Names Chief of Hematologic MalignanciesJuly 13th, 2021
  • Children’s Hospital of Philadelphia Appoints Leukemia Specialist as Section Chief
    Children’s Hospital of Philadelphia Appoints Leukemia Specialist as Section ChiefJuly 11th, 2021
  • Long-Term Repercussions of Postponing Care Due to COVID-19
    Long-Term Repercussions of Postponing Care Due to COVID-19March 8th, 2021
  • Join now to see all

Grant Support

  • Post Graduate Training In Pediatric OncologyNational Cancer Institute2011
  • Molecular Signatures For Outcome Prediction And Therapeutic Targeting In AllNational Cancer Institute2011
  • Identifying The Spectrum Of Genetic Alterations In High Risk AllNational Cancer Institute2010
  • Targeted Therapies For Childhood Acute Lymphoblastic LeukemiaNational Cancer Institute2009–2010
  • Postgraduate Training In Pediatric OncologyNational Cancer Institute2008–2009
  • Phase I Study Of Erbitux (CETUXIMAB) In Ped Subj With Solid Tumors Ca225-085National Center For Research Resources2007
  • Anbl0032, Phase III Randomized Study Of Chimeric Anti-Gd2 In High Risk NeuroblaeNational Center For Research Resources2007
  • A Multicenter Phase I Trial Of 17-N-Allylamino-17-Demethoxy GeldanamycinNational Center For Research Resources2006
  • A Multicenter Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AsNational Center For Research Resources2005
  • Measuring Asparagine Synthetase Expression In LeukemiaNational Cancer Institute2004–2005
  • Functional Analysis Of The T(17--19)-All Chimera E2A-HLFNational Cancer Institute1998
  • Molecular Analysis Of Chromosomal TranslocationsNational Cancer Institute1991–1993

Hospital Affiliations